Biaryl substituted 6-membered heterocyles as sodium channel blockers

Details for Australian Patent Application No. 2004224392 (hide)

Owner Merck & Co., Inc.

Inventors Liang, Jun; Fisher, Michael H.; Chakravarty, Prasun K.; Parsons, William H.; Zhou, Bishan

Agent Spruson & Ferguson

Pub. Number AU-A-2004224392

PCT Pub. Number WO2004/084824

Priority 60/456,312 24.03.03 US

Filing date 19 March 2004

Wipo publication date 7 October 2004

International Classifications

C07D 213/26 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/084824 Priority application(s): WO2004/084824

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224393-High viscosity xanthan polymer preparations

2004224390-Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof